Paysign Inc (PAYS)

[chilar4567]

Paysign, Inc. Reports Second Quarter 2024 Financial Results
4:02 PM ET 7/31/24 | BusinessWire
Related Quotes


4:00 PM ET 7/31/24
Symbol Last % Chg
PAYS
5.33 2.11%
Real time quote.

-- Second quarter 2024 total revenues of $14.33 million, up 29.8% from
second quarter 2023

-- Second quarter 2024 net income of $697 thousand, or diluted earnings per
share of $0.01, versus net loss of $104 thousand, or diluted earnings per
share of $(0.00) for second quarter 2023

-- Second quarter 2024 Adjusted EBITDA of $2.24 million, up 95.8% from $1.14
million for second quarter 2023, while diluted Adjusted EBITDA per share
was $0.04 versus $0.02 for second quarter 20231

-- Total plasma center count increased by eight net new centers during
second quarter 2024, exiting the quarter with 477 centers, contributing
to a 12.6% increase in plasma revenue versus the same period last year

-- Added eight net new patient affordability programs during second quarter
2024, exiting the quarter with 61 active programs, leading to a 266.8%
increase in pharma patient affordability revenue over the same period
last year

-- Exited the quarter with $31.29 million of unrestricted cash and zero
debt; $22.71 million related to payment timing on pass-through claim
reimbursement receivables and related payables

-- Second quarter 2024 gross dollar load volume was up 12.7% compared to
second quarter 2023

-- Second quarter 2024 gross spend volume was up 11.2% compared to second
quarter 2023

-- Second quarter 2024 average revenue per plasma center per month of
$7,916, up 4.4%, versus $7,581 for second quarter 2023

-- Second quarter 2024 patient affordability claim volume increased 365.5%,
versus second quarter 2023